Skip to content
Primary Menu
Clinical
Medications for Opioid Use Disorder (MOUD)
Pain or Opioid Withdrawal in Hospitalized Patients
Low dose/Microdose Buprenorphine Instructions
Buprenorphine Induction Pathway
Perinatal Resources for Opioid Use Disorder (PROUD)
All About Xylazine
Substance Use Navigator Team
Success Stories
Education
Working as a Peer in Recovery
How to Mitigate Stigma
All About the X Waiver
Addiction Medicine Interest Group
Research
Clinical Trials
Research in the News
Publications
Harm Reduction
All About Fentanyl
All About Xylazine
How to Use Narcan
Harm Reduction Interest Group
Trainings & Events
Trainings
Upcoming Events
Events Archive
News & Policy
Policy
About Us
Donate
Leadership
CAMP Team
Advisory Board
Newsletters
Get Help
Participation in a Hospital Incentive Program for Follow-up Treatment for Opioid Use Disorder
Post navigation
Previous:
Providing Incentive for Emergency Physician X-Waiver Training: An Evaluation of Program Success and Postintervention Buprenorphine Prescribing
Next:
Opioid Use Disorder and COVID-19: Crashing of the Crises. Khatri UG, Perrone J.
Clinical
Medications for Opioid Use Disorder (MOUD)
Pain or Opioid Withdrawal in Hospitalized Patients
Low dose/Microdose Buprenorphine Instructions
Buprenorphine Induction Pathway
Perinatal Resources for Opioid Use Disorder (PROUD)
All About Xylazine
Substance Use Navigator Team
Success Stories
Education
Working as a Peer in Recovery
How to Mitigate Stigma
All About the X Waiver
Addiction Medicine Interest Group
Research
Clinical Trials
Research in the News
Publications
Harm Reduction
All About Fentanyl
All About Xylazine
How to Use Narcan
Harm Reduction Interest Group
Trainings & Events
Trainings
Upcoming Events
Events Archive
News & Policy
Policy
About Us
Donate
Leadership
CAMP Team
Advisory Board
Newsletters
Get Help
